The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Pulmonary exacerbation in adults with bronchiectasis: a consensus definition for clinical research
Open accessAbstract
There is a need for a clear definition of exacerbations used in clinical trials in patients with bronchiectasis. An expert conference was convened to develop a consensus definition of an exacerbation for use in clinical research. A systematic review of exacerbation definitions used in clinical trials from January 2000 until December 2015 and involving adults with bronchiectasis was conducted. A Delphi process followed by a round-table meeting involving bronchiectasis experts was organised to reach a consensus definition. These experts came from Europe (representing the European Multicentre Bronchiectasis Research Collaboration), North America (representing the US Bronchiectasis Research Registry/COPD Foundation), Australasia and South Africa. The definition was unanimously approved by the working group as: a person with bronchiectasis with a deterioration in three or more of the following key symptoms for at least 48 h: cough; sputum volume and/or consistency; sputum purulence; breathlessness and/or exercise tolerance; fatigue and/or malaise; haemoptysis AND a clinician determines that a change in bronchiectasis treatment is required. The working group proposes the use of this consensus-based definition for bronchiectasis exacerbation in future clinical research involving adults with bronchiectasis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Consensus development methods, and their use in clinical guideline development.
Murphy, Black, Lamping, McKee, Sanderson, Askham, & Marteau (1998) · Health Technology Assessment · doi:10.3310/hta2030 · Cited by 2,051
British Thoracic Society guideline for non-CFbronchiectasis
Pasteur, M. C., Bilton, D., Hill, A. T., & on behalf of the British Thoracic Society Bronchiectasis (non-CF) Guideline Group (2010) · Thorax · doi:10.1136/thx.2010.136119 · Cited by 1,046
Self-citationFitzpatrick, Shortall, Sculpher, Murray, Morris, Lodge, Dawson, Carr, Britton, & Briggs (1998) · Health Technology Assessment · doi:10.3310/hta2200 · Cited by 969
Wong, C., Jayaram, L., Karalus, N., Eaton, T., Tong, C., Hockey, H., Milne, D., Fergusson, W., Tuffery, C., Sexton, P., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60953-2 · Cited by 600
Altenburg, J., de Graaff, C. S., Stienstra, Y., Sloos, J. H., van Haren, E. H. J., Koppers, R. J. H., van der Werf, T. S., & Boersma, W. G. (2013) · JAMA · doi:10.1001/jama.2013.1937 · Cited by 518
Self-citationSerisier, D. J., Martin, M. L., McGuckin, M. A., Lourie, R., Chen, A. C., Brain, B., Biga, S., Schlebusch, S., Dash, P., & Bowler, S. D. (2013) · JAMA · doi:10.1001/jama.2013.2290 · Cited by 420
Chalmers, J. D., Smith, M. P., McHugh, B. J., Doherty, C., Govan, J. R., & Hill, A. T. (2012) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201203-0487oc · Cited by 410
Self-citationA Randomized Controlled Trial of Nebulized Gentamicin in Non–Cystic Fibrosis Bronchiectasis
Murray, M. P., Govan, J. R. W., Doherty, C. J., Simpson, A. J., Wilkinson, T. S., Chalmers, J. D., Greening, A. P., Haslett, C., & Hill, A. T. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201005-0756oc · Cited by 297
Self-citationInhaled Colistin in Patients with Bronchiectasis and Chronic Pseudomonas aeruginosa Infection
Haworth, C. S., Foweraker, J. E., Wilkinson, P., Kenyon, R. F., & Bilton, D. (2014) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201312-2208oc · Cited by 264
Self-citationMacLeod, Grant, Donaldson, Khan, Campbell, Daly, Lawrence, Wallace, Vale, Cody, et al. (1998) · Health Technology Assessment · doi:10.3310/hta2050 · Cited by 254
Serisier, D. J., Bilton, D., De Soyza, A., Thompson, P. J., Kolbe, J., Greville, H. W., Cipolla, D., Bruinenberg, P., Gonda, I., & the ORBIT-2 investigators (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203207 · Cited by 250
Self-citationBarker, A. F., O'Donnell, A. E., Flume, P., Thompson, P. J., Ruzi, J. D., de Gracia, J., Boersma, W. G., De Soyza, A., Shao, L., Zhang, J., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70165-1 · Cited by 220
Self-citationDiagnóstico y tratamiento de las bronquiectasias
Vendrell, M., de Gracia, J., Olveira, C., Ángel Martínez, M., Girón, R., Máiz, L., Cantón, R., Coll, R., Escribano, A., & Solé, A. (2008) · Archivos de Bronconeumología · doi:10.1157/13128330 · Cited by 213
Self-citationWilson, R., Welte, T., Polverino, E., De Soyza, A., Greville, H., O'Donnell, A., Alder, J., Reimnitz, P., & Hampel, B. (2013) · European Respiratory Journal · doi:10.1183/09031936.00071312 · Cited by 202
Self-citationValery, P. C., Morris, P. S., Byrnes, C. A., Grimwood, K., Torzillo, P. J., Bauert, P. A., Masters, I. B., Diaz, A., McCallum, G. B., Mobberley, C., et al. (2013) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(13)70185-1 · Cited by 189
A randomised crossover trial of chest physiotherapy in non-cystic fibrosis bronchiectasis
Murray, M. P., Pentland, J. L., & Hill, A. T. (2009) · European Respiratory Journal · doi:10.1183/09031936.00055509 · Cited by 189
Self-citationInhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial
Bilton, D., Tino, G., Barker, A. F., Chambers, D. C., De Soyza, A., Dupont, L. J. A., O'Dochartaigh, C., van Haren, E. H. J., Vidal, L. O., Welte, T., et al. (2014) · Thorax · doi:10.1136/thoraxjnl-2014-205587 · Cited by 170
Self-citationLee, A. L., Hill, C. J., Cecins, N., Jenkins, S., McDonald, C. F., Burge, A. T., Rautela, L., Stirling, R. G., Thompson, P. J., & Holland, A. E. (2014) · Respiratory Research · doi:10.1186/1465-9921-15-44 · Cited by 161
The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis
Nicolson, C., Stirling, R. G., Borg, B. M., Button, B., Wilson, J. W., & Holland, A. E. (2012) · Respiratory Medicine · doi:10.1016/j.rmed.2011.12.021 · Cited by 155
Assessing response to treatment of exacerbations of bronchiectasis in adults
Murray, M., Turnbull, K., MacQuarrie, S., & Hill, A. T. (2008) · European Respiratory Journal · doi:10.1183/09031936.00122508 · Cited by 125
Self-citationBilton, D., Daviskas, E., Anderson, S. D., Kolbe, J., King, G. G., Stirling, R. G., Thompson, B. R., Milne, D. G., & Charlton, B. (2013) · CHEST Journal · doi:10.1378/chest.12-1763 · Cited by 119
Atorvastatin as a stable treatment in bronchiectasis: a randomised controlled trial
Mandal, P., Chalmers, J. D., Graham, C., Harley, C., Sidhu, M., Doherty, C. J., Govan, J. R. W., Sethi, T., Davidson, D. J., Rossi, A. G., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70050-5 · Cited by 95
Self-citationDefining pulmonary exacerbation in children with non‐cystic fibrosis bronchiectasis
Kapur, N., Masters, I. B., Morris, P. S., Galligan, J., Ware, R. S., & Chang, A. B. (2011) · Pediatric Pulmonology · doi:10.1002/ppul.21518 · Cited by 87
Budesonide efficacy and safety in patients with bronchiectasis not due to cystic fibrosis
Hernando, R., Drobnic, M. E., Cruz, M. J., Marcellés, A. F., Suñé, P., Ronsano, J. B. M., & Orriols, R. (2012) · International Journal of Clinical Pharmacy · doi:10.1007/s11096-012-9659-6 · Cited by 51
Cited by
European Respiratory Society guidelines for the management of adult bronchiectasis
Polverino, E., Goeminne, P. C., McDonnell, M. J., Aliberti, S., Marshall, S. E., Loebinger, M. R., Murris, M., Cantón, R., Torres, A., Dimakou, K., et al. (2017) · European Respiratory Journal · doi:10.1183/13993003.00629-2017 · Cited by 1,333
Self-citationAdvances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity
Flume, P. A., Chalmers, J. D., & Olivier, K. N. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31767-7 · Cited by 545
Self-citationPhase 2 Trial of the DPP-1 Inhibitor Brensocatib in Bronchiectasis
Chalmers, J. D., Haworth, C. S., Metersky, M. L., Loebinger, M. R., Blasi, F., Sibila, O., O’Donnell, A. E., Sullivan, E. J., Mange, K. C., Fernandez, C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2021713 · Cited by 377
Self-citationChalmers, J. D., Chang, A. B., Chotirmall, S. H., Dhar, R., & McShane, P. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0042-3 · Cited by 351
Self-citationChalmers, J. D., Polverino, E., Crichton, M. L., Ringshausen, F. C., De Soyza, A., Vendrell, M., Burgel, P. R., Haworth, C. S., Loebinger, M. R., Dimakou, K., et al. (2023) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(23)00093-0 · Cited by 315
Self-citation
Metadata
- Authors
- Hill, A. T., Haworth, C. S., Aliberti, S., Barker, A., Blasi, F., Boersma, W., Chalmers, J. D., De Soyza, A., Dimakou, K., Elborn, J. S., Feldman, C., Flume, P., Goeminne, P. C., Loebinger, M. R., Menendez, R., Morgan, L., Murris, M., Polverino, E., Quittner, A., Ringshausen, F. C., Tino, G., Torres, A., Vendrell, M., Welte, T., Wilson, R., Wong, C., O'Donnell, A., & Aksamit, T.
- Venue
- European Respiratory Journal
- Publisher
- European Respiratory Society (ERS)
- Published
- 2017-06
- Volume
- 49
- Issue
- 6
- Pages
- 1700051
- ISSN
- 0903-1936 (ISSN-L)
- 1399-3003
- OpenAlex
- W2623856550
- Cited by
- 439
- References
- 24
- FWCI
- 27.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.